Obesity
Conference Coverage
Tirzepatide lowers weight across all groups with obesity
The antiobesity medication semaglutide “took things up one big notch, and now tirzepatide is up a little notch above that,” one expert said.
Latest News
Link between PCOS and increased risk of pancreatic cancer?
“These data suggest some individuals may have unknown metabolic derangements that may underlie the development of both conditions.”
Feature
Why it’s harder for MDs to lose weight
A doctor set out to create a weight-loss program rooted in the physical and mental demands of medical practice. In the process, she lost 45 pounds...
Conference Coverage
STEP TEENS: Semaglutide ‘gives hope’ to adolescents with obesity
“We are getting close to bariatric surgery results” in these adolescent patients with obesity. To have 40% of patients attain normal weight, “that...
Conference Coverage
ObesityWeek 2022: What’s stopping effective treatment of obesity?
In the biggest international conference on obesity, delegates will discuss obesity in children and barriers to use of newer anti-obesity drugs,...
Opinion
BMI and reproduction – weighing the evidence
Female obesity is related to poorer outcomes in natural and assisted conception, including an increased risk of miscarriage.
Conference Coverage
Risk factors ID’d for acute pancreatitis from weight-loss drugs
“With obesity being such a global issue, there are many patients on these GLP-1 agonists.”
Conference Coverage
Don’t be afraid of weight gain with hyperthyroid treatment
A large study shows highest weight gain risk is with thyroidectomy, and radioiodine therapy is linked to better survival.
Guidelines
New AGA guidelines advise use of antiobesity medications for weight management
Though lifestyle interventions are the first-line treatment for overweight and obesity, use of specific pharmacological agents should be...
Latest News
Instagram may make new moms feel inadequate: Study
“This is a deeper issue of how women are overall portrayed in the media and the pressure we face to return to some unrealistic size.”
From the Journals
It’s about location: PCOS symptoms differ depending where you live
Women with PCOS in California were more likely to have hyperandrogenemia than were those in Alabama, but age and BMI weren’t factors, nor was race...